2/3
09:00 am
pstv
Plus Therapeutics (NASDAQ:PSTV) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $2.00 price target on the stock.
Low
Report
Plus Therapeutics (NASDAQ:PSTV) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $2.00 price target on the stock.
2/3
08:38 am
pstv
Plus Therapeutics initiated with a Buy at Lake Street
Low
Report
Plus Therapeutics initiated with a Buy at Lake Street
2/3
08:38 am
pstv
Plus Therapeutics initiated with a Buy at Lake Street
Low
Report
Plus Therapeutics initiated with a Buy at Lake Street
1/23
07:09 am
pstv
Plus Therapeutics (NASDAQ:PSTV) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Plus Therapeutics (NASDAQ:PSTV) had its "buy" rating reaffirmed by analysts at HC Wainwright.
11/26
10:59 am
pstv
Plus Therapeutics (NASDAQ:PSTV) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Plus Therapeutics (NASDAQ:PSTV) had its "buy" rating reaffirmed by analysts at HC Wainwright.
11/21
05:45 am
pstv
Rating for PSTV
High
Report
Rating for PSTV